Title Category Credit Event date Cost
Hybrid ablation: a role in AF management?
  • European Board for Accreditation in Cardiology (EBAC)
£0.00 OverviewJoin a panel of International faculty as they discuss the clinical value of hybrid ablation treatment strategies for persistent atrial fibrillation (AF).Can it improve patient outcomes? What evidence base is available to support this? How can it be implemented effectively in clinical practice?Available from 06/07/2018 until 06/07/2023. 
ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma
£0.00 Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 entitled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials.Filmed on site at ACC 2019 by Radcliffe Cardiology Videography: Josh BirchInterviewer: Liam O'Neill
Course: Utilizing NOAC's in non-valvular atrial fibrillation patients undergoing PCI
  • Attendance
£0.00 OverviewThis independent medical education (IME) series has been created  for English, German and Spanish speaking cardiologists and is designed to showcase the latest updates emerging from the data in novel oral anticoagulants in non-valvular atrial fibrillation patients undergoing PCI.
Convergent procedure: A new approach to atrial fibrillation ablation
  • European Board for Accreditation in Cardiology (EBAC)
£0.00 OverviewThe cornerstone of atrial fibrillation (Afib) is electrical isolation of the pulmonary veins (PV).